Log in to search using one of your social media accounts:

VIDEO: RA patients on subcutaneous methotrexate avoid biologics
LONDON – Subcutaneous methotrexate monotherapy may be more effective at helping recently diagnosed patients with rheumatoid arthritis avoid biologic therapy, compared with similar patients on oral... (Source: Family Practice News)
Source: Family Practice News - June 20, 2016 Category: Primary Care Source Type: news

Obesity and smoking 'reduce chances of successful arthritis treatment'
People with rheumatoid arthritis would be well advised to quit smoking and get in shape in order to maximise their chances of being treated successfully.This is according to a new study from McGill University in Montreal, Canada, which indicated that the likelihood of achieving sustained remission in early rheumatoid arthritis is significantly lower in patients who smoke and who are obese.The negative impact of unhealthy living For this research, presented at the recent European League Against Rheumatism annual congress, scientists assessed the impact of patients' body mass index scores and smoking habits on the ti...
Source: Arthritis Research UK - June 19, 2016 Category: Rheumatology Source Type: news

HIGH-ly Recommended: 11 Cannabis Products That Are Totally Legal
New York -- We didn't find Mary Jane, but we did find CBD.  Leaders of the legalized marijuana and hemp industries flocked to New York City's Jacob Javitz Center this week for the Cannabis World Congress & Business Expo, and the mood there was clearly upbeat. The prevailing thought: Countrywide legalization is coming. The only question is how fast. Leaders believe the U.S. market will be a $35 billion behemoth by 2020, stretching from high-end lifestyle products and pharmaceuticals to just about everything else. This is "the definitive business event for the cannabis industry" and it's no joke. It's...
Source: Science - The Huffington Post - June 17, 2016 Category: Science Source Type: news

Single Rituximab Injection Delays RA in High-Risk PatientsSingle Rituximab Injection Delays RA in High-Risk Patients
A single infusion of the anti-CD20 antibody rituximab, intended to deplete the B-cell population, delays the onset of rheumatoid arthritis in high-risk patients, results from the PRAIRI study suggest. Medscape Medical News (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - June 17, 2016 Category: Orthopaedics Tags: Rheumatology News Source Type: news

Biosimilar therapies for rheumatoid arthritis 'not suitable for all patients'
Biosimilar treatments for rheumatoid arthritis may not be suitable for all patients, according to a new study.Presented at the European League Against Rheumatism's annual congress, the research - led by Progenika Biopharma in Spain - indicated that certain patients who are not able to benefit from treatment with anti-TNF therapies are unlikely to experience a better response by switching to a biosimilar version.The need for better understanding of biosimilars As their name suggests, biosimilar therapies are based on existing licensed drugs and are not identical, but are chemically similar enough to provide equivale...
Source: Arthritis Research UK - June 16, 2016 Category: Rheumatology Source Type: news

Diabetes 'more frequent in children with juvenile inflammatory arthritis'
This study backs up recent findings that diabetes is more common in people with rheumatoid arthritis than the general population; however, the reasons for this are not yet well understood. There is a growing appreciation of the links between different autoimmune diseases, and further research will be important to fully understand the relationship between juvenile inflammatory arthritis and diabetes - an approach that may lead to new treatments for both conditions." (Source: Arthritis Research UK)
Source: Arthritis Research UK - June 16, 2016 Category: Rheumatology Source Type: news

New Alternative Treatments For Kidney Problems
There’s something you should know about chronic kidney disease. Most doctors will tell you there is no alternative treatments for kidney problems besides costly dialysis or a transplant to deal with impaired renal function. What Is Kidney Failure? Kidney dialysis is a treatment that uses a special machine to filter harmful wastes, salt and excess from your blood. But there is another option. It’s called stem cell biotherapy, and it offers new hope to those with this life-threatening disease. You may think your kidneys are just fine and you have nothing to worry about. But consider this… What Causes Kidn...
Source: Al Sears, MD Natural Remedies - June 16, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Health Source Type: news

Vitamin D may not be the great solution to health problems
A new review examines the evidence for 10 common beliefs about vitamin D. The beliefs range from the ability of vitamin D to reduce falls and fractures, improve depression and mental well-being, prevent rheumatoid arthritis, treat Multiple Sclerosis, and lessen incidences of cancer and mortality. The review finds little evidence though that supplementation with this vitamin has much of an effect at all. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 16, 2016 Category: Science Source Type: news

Medical News Today: Rheumatoid arthritis patients experience long-term benefits with new drug
The medication olokizumab improves outcomes for up to 48 weeks in patients with rheumatoid arthritis, investigators recently reported at a conference. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 16, 2016 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Vitamin D may not be the great solution to health problems
(University of Alberta Faculty of Medicine & Dentistry) A review published in the Journal of General Internal Medicine examines the evidence for 10 common beliefs about vitamin D. The beliefs range from the ability of vitamin D to reduce falls and fractures, improve depression and mental well-being, prevent rheumatoid arthritis, treat Multiple Sclerosis, and lessen incidences of cancer and mortality. The review finds little evidence though that supplementation with this vitamin has much of an effect at all. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 16, 2016 Category: Biology Source Type: news

Tai chi may be as good as physical therapy for arthritis-related knee pain
This study was relatively small and lasted only one year — yet osteoarthritis symptoms can last decades. So, we’ll need larger and longer studies of tai chi in osteoarthritis before we can confidently say that it’s a long-term treatment for a long-term condition. Still, this new report is encouraging. Not so long ago, proponents of “complementary and alternative” treatments such as tai chi routinely met resistance from patients and doctors who wanted to see evidence that these treatments actually work. In recent years, that long-awaited evidence has begun piling up. This new study is just the ...
Source: New Harvard Health Information - June 15, 2016 Category: Consumer Health News Authors: Robert H. Shmerling, MD Tags: Arthritis Complementary and alternative medicine Health Osteoarthritis Pain Management Source Type: news

TNF blocker safety may differ in RA and psoriasis patients
Rheumatoid arthritis patients on anti–tumor necrosis factor medications had approximately twice the rate of serious adverse events as did psoriasis patients on the same medications, based on data from a pair of prospective studies of about 4,000 adults. The findings were published online in the... (Source: Skin and Allergy News)
Source: Skin and Allergy News - June 14, 2016 Category: Dermatology Source Type: news

Certolizumab Combo Helps Curb RA DamageCertolizumab Combo Helps Curb RA Damage
Certolizumab pegol (Cimzia, UCB Pharma) in combination with methotrexate does better than methotrexate alone in certain patients with early rheumatoid arthritis (RA), according to one-year results from a new trial. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 14, 2016 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Repetitive physical workloads 'can increase risk of rheumatoid arthritis'
People whose jobs involve carrying out repetitive physical tasks could be at an elevated risk of developing rheumatoid arthritis.This is according to a new study from Sweden's Karolinska Institute, which was presented at the European League Against Rheumatism's annual congress and represents the first study to show a link between physical workloads and rheumatoid arthritis.The impact of certain types of work The research examined data from 3,680 rheumatoid arthritis patients and 5,935 matched controls from the Swedish Epidemiological Investigation of Rheumatoid Arthritis study, revealing that some types of ...
Source: Arthritis Research UK - June 13, 2016 Category: Rheumatology Source Type: news

Smoking, Weight Gain Barriers to Remission in Early RASmoking, Weight Gain Barriers to Remission in Early RA
Smoking and obesity have again been singled out as reasons that early measures to control rheumatoid arthritis (RA) might fail. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 11, 2016 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Motivational text messages and counselling boost health of patients with RA
Motivational text messages and counselling boost health of patients with rheumatoid arthritis (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 11, 2016 Category: Science Source Type: news

Prolonged repetitive physical workload increases risk of developing rheumatoid arthritis
The results of a new study showed that prolonged repetitive physical workload increases the risk of developing rheumatoid arthritis (RA). Although work-related physical activity over many years is known to cause many cases of osteoarthritis (OA) in selected joints, this is the first study to show a link between physical workload and RA. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 10, 2016 Category: Science Source Type: news

Rheumatoid Factor Isotypes Before the Onset of RARheumatoid Factor Isotypes Before the Onset of RA
Can we predict the development of rheumatoid arthritis years before the onset of symptoms? Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 10, 2016 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

VIDEO: Smoking, excess weight hinder sustained remission in early RA
LONDON – Tobacco use and excess weight can make it harder to achieve sustained remission in the treatment of early rheumatoid arthritis, according to findings from more than 1,000 patients in the... (Source: Family Practice News)
Source: Family Practice News - June 10, 2016 Category: Primary Care Source Type: news

Disjointed: Cell differences may explain why rheumatoid arthritis varies by location
Not only are there distinct differences in key cellular processes and molecular signatures between rheumatoid arthritis (RA) and osteoarthritis (OA) but, more surprisingly, there are joint-specific differences in RA, report researchers. The findings help explain why drugs treating RA vary in effect and provide a potential new template for precisely targeting treatment for each and every ailing joint. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 10, 2016 Category: Science Source Type: news

EU wants more transparency on AbbVie's Humira, world's top drug
LONDON (Reuters) - Details of clinical trials involving AbbVie's rheumatoid arthritis drug Humira, the world's top-selling prescription medicine, are still being withheld without justification, according to the European Union's ombudsman. (Source: Reuters: Health)
Source: Reuters: Health - June 10, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Hydroxychloroquine, abatacept linked with reduced type 2 diabetes
LONDON – U.S. rheumatoid arthritis patients had a significantly reduced incidence of type 2 diabetes when on treatment with either hydroxychloroquine or abatacept in an analysis of more than 13,000... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - June 10, 2016 Category: Endocrinology Source Type: news

Obesity and smoking reduces likelihood of treatment success in early rheumatoid arthritis
Presented at the European League Against Rheumatism Annual Congress, research showed that the likelyhood of remission in early RA is significantly lower in patients who are obese or who smoke. Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - June 10, 2016 Category: Endocrinology Source Type: news

Positive mental attitude improves treatment adherence in rheumatoid arthritis
(European League Against Rheumatism) Positive mental attitude improves treatment adherence in rheumatoid arthritis (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 10, 2016 Category: Global & Universal Source Type: news

One third of rheumatoid arthritis patients experience sexual dysfunction
(European League Against Rheumatism) One third of rheumatoid arthritis patients experience sexual dysfunction. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 10, 2016 Category: Global & Universal Source Type: news

Disjointed: Cell differences may explain why rheumatoid arthritis varies by location
(University of California - San Diego) Researchers at the University of California San Diego School of Medicine, with colleagues in Pennsylvania and China, report that not only are there distinct differences in key cellular processes and molecular signatures between rheumatoid arthritis (RA) and osteoarthritis (OA) but, more surprisingly, there are joint-specific differences in RA. The findings help explain why drugs treating RA vary in effect and provide a potential new template for precisely targeting treatment for each and every ailing joint. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 10, 2016 Category: Global & Universal Source Type: news

Prolonged repetitive physical workload increases risk of developing rheumatoid arthritis
(European League Against Rheumatism) Prolonged repetitive physical workload increases risk of developing rheumatoid arthritis (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 10, 2016 Category: Global & Universal Source Type: news

Motivational text messages and counselling boost health of patients with RA
(European League Against Rheumatism) Motivational text messages and counselling boost health of patients with rheumatoid arthritis (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 10, 2016 Category: Global & Universal Source Type: news

UK rheumatologists go beyond NICE guidance on cost when treating RA patients
(European League Against Rheumatism) UK rheumatologists go beyond NICE guidance on cost when treating rheumatoid arthritis patients (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 10, 2016 Category: Global & Universal Source Type: news

Obesity and smoking reduces likelihood of treatment success in early rheumatoid arthritis
The results of a study showed that the likelihood of achieving sustained remission in early rheumatoid arthritis (RA) is significantly lower in patients who smoke and who are obese. These findings suggest that encouraging patients to stop smoking and to achieve a healthy body weight could significantly improve their chance of becoming symptom-free after adequate treatment. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 9, 2016 Category: Science Source Type: news

Gene profiling can help predict treatment response and could save money in RA
Two new studies have shown that the use of gene profiling designed to predict a positive response to treatment in rheumatoid arthritis (RA) patients is following the lead from its use in cancer treatment. Prompt identification of those RA patients not responding to treatment supports timely switching to alternative treatment, reducing the chance of long-term joint damage and avoiding money being wasted on ineffective drugs. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 9, 2016 Category: Science Source Type: news

Early, efficient detection and treatment of rheumatoid arthritis using new delivery system
The results of a new study showed that tiny particles made of a biodegradable polymer (BNPs -- biodegradable polymer nanoparticles) have the potential to enable early detection and efficient long-term treatment of rheumatoid arthritis (RA), with minimal side effects. By coating these particles with a peptide that is only able to target inflamed joint tissue, BNPs may be used to efficiently and selectively deliver drugs and diagnostic probes into arthritic joints. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 9, 2016 Category: Science Source Type: news

Osteoarthritis just as severe as rheumatoid arthritis
The results of a new study showed patients with osteoarthritis (OA) are more likely to have the impact of their condition underestimated by rheumatologists than patients with Rheumatoid Arthritis (RA). (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 9, 2016 Category: Science Source Type: news

Can Rheumatoid Arthritis Cause Hearing Loss?
When I have a patient with rheumatoid arthritis (RA), I like to test their hearing. Most doctors think I’m crazy. They don’t get the connection between your hearing and your joints. But it’s clearly there. When you have RA, your immune system mistakes your bones, cartilage, and connective tissues for hostile invaders. It attacks and breaks down the joints. The result is a crippling loss of mobility. But RA doesn’t stop at the joints. It can affect the entire body. About 15% to 25% of RA patients have “extra-articular” RA. This form of the disease can attack your heart, lungs, blood vess...
Source: Al Sears, MD Natural Remedies - June 9, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Health Source Type: news

Gout Hospitalizations Outpace Those for Rheumatoid ArthritisGout Hospitalizations Outpace Those for Rheumatoid Arthritis
Despite a decline in hospitalizations related to rheumatoid arthritis, hospitalizations primarily associated with gout have increased dramatically during the last 2 decades. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 9, 2016 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Obesity and smoking reduces likelihood of treatment success in early rheumatoid arthritis
(European League Against Rheumatism) Obesity and smoking reduces likelihood of treatment success in early rheumatoid arthritis (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 9, 2016 Category: Global & Universal Source Type: news

IL-6 Blockade Stops RA Damage
(MedPage Today) -- Sirukumab inhibited radiographic progression in rheumatoid arthritis at 1 year (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 8, 2016 Category: Primary Care Source Type: news

Impact of Osteoarthritis Underrated by RheumatologistsImpact of Osteoarthritis Underrated by Rheumatologists
Rheumatologists are more likely to underestimate the impact of osteoarthritis than rheumatoid arthritis, even though patients with osteoarthritis often have more pain and a greater burden of disease. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 8, 2016 Category: Consumer Health News Tags: Rheumatology News Source Type: news

GSK, J&J Reveal RA Drug Phase III Results
A study of sirukumab meets both co-primary endpoints in patients with moderately to severely active rheumatoid arthritis (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - June 8, 2016 Category: Pharmaceuticals Source Type: news

PRP Therapy: Play Hard, Heal Fast
There’s a way to heal sports injuries that doesn’t involve surgery, months of physical therapy or a dependence on prescription medication. It’s called platelet-rich plasma (PRP) therapy. What Is PRP Therapy? It’s a form of stem cell treatment that uses platelets — colorless blood cells that help your blood clot — to rebuild a damaged tendon or cartilage. It not only relieves the pain, it also jumpstarts the healing process.   That’s because platelets contain hundreds of proteins called “growth factors.” The natural growth factors in PRP can actually regenerate inj...
Source: Al Sears, MD Natural Remedies - June 8, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Anti-Aging Source Type: news

Anti-TNF study sheds new light on how they function
In this study, the researchers observed that treating rheumatoid arthritis patients with adalimumab helped to increase the number of regulatory T cells that suppressed inflammation in the body. It was previously assumed that this was because TNF stops the development of these anti-inflammatory cells.However, the new study revealed that in actual fact, TNF actually triggers the formation of anti-inflammatory T cells, and that adalimumab is capable of enhancing this process at the same time as stopping TNF's pro-inflammatory effects.Michael Ehrenstein and colleagues at University College London said: "These resu...
Source: Arthritis Research UK - June 7, 2016 Category: Rheumatology Source Type: news

J&J, GSK rheumatoid arthritis drug meets goals of large trial
(Reuters) - An experimental drug for rheumatoid arthritis developed by Johnson & Johnson and GlaxoSmithKline slowed joint damage and improved symptoms of the disease, meeting the main goals of a large, late stage trial, according to data released on Tuesday. (Source: Reuters: Health)
Source: Reuters: Health - June 7, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Rheumatoid arthritis: clinical review
The epidemiology, aetiology, diagnosis, monitoring and treatment of rheumatoid arthritis, including the latest advice on investigations and the role of early referral and treatment in halting disease progression. (Source: GP Online Education)
Source: GP Online Education - June 7, 2016 Category: Primary Care Tags: 15.9 Rheumatology, Musculoskeletal and Trauma Source Type: news

Hunting growth, Samsung races to get up to speed on biosimilar drugs
SEOUL (Reuters) - As Samsung Bioepis raced to be first to market with a copy of Enbrel, a blockbuster rheumatoid arthritis drug, countdown clocks reminded workers - heading for lunch, meetings or even the washroom - of the days to the first mass production run. (Source: Reuters: Health)
Source: Reuters: Health - June 6, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Etanercept/methotrexate treatment for rheumatoid arthritis 'can be safely tapered'
This study adds to the growing body of evidence that in some patients who have responded well to treatment, doses could be reduced or even stopped altogether without them experiencing a change in effect. This work is still in the early stages, and it is important that people with arthritis consult their rheumatologist before reducing dosage of any prescribed medication." (Source: Arthritis Research UK)
Source: Arthritis Research UK - June 6, 2016 Category: Rheumatology Source Type: news

Rheumatoid Arthritis - Remicade
Rheumatoid Arthritis - My Doctor Says I Need Remicade (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 6, 2016 Category: Journals (General) Source Type: news

Novel Treatment Options Explored at Rheumatology CongressNovel Treatment Options Explored at Rheumatology Congress
Alternative therapies for rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus will be presented at the upcoming European League Against Rheumatism (EULAR) Congress 2016. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 2, 2016 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Can-Fite BioPharma to initiate Phase III trial of piclidenoson to treat rheumatoid arthritis
Can-Fite BioPharma, an advanced clinical stage drug development company, has reached an agreement with the European Medicines Agency (EMA) to design a global Phase III trial for piclidenoson (CF101), a new A3 adenosine receptor agonist (A3AR) small m… (Source: Drug Development Technology)
Source: Drug Development Technology - June 1, 2016 Category: Pharmaceuticals Source Type: news

Stay Active With RA and Keep Up the Fun
WebMD explains how some smart planning and the right moves can let you enjoy travel, evenings out, and hobbies, even if your rheumatoid arthritis flares up. (Source: WebMD Health)
Source: WebMD Health - June 1, 2016 Category: Consumer Health News Source Type: news

How to Do Household Chores When You Have RA
WebMD describes tips, tricks, and gadgets to help keep your house tidy when you have rheumatoid arthritis. (Source: WebMD Health)
Source: WebMD Health - June 1, 2016 Category: Consumer Health News Source Type: news